Trial Profile

Advanced Molecular Imaging With Anti-3-[18F]FACBC PET-CT to Improve the Selection and Outcomes of Prostate Cancer Patients Receiving Post-prostatectomy Radiotherapy

Status: Completed

Phase of Trial: Phase II/III

Latest Information Update: 03 Aug 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Fluciclovine 18F (Primary)
Indications Adenocarcinoma; Prostate cancer
Focus Therapeutic Use
Acronyms EMPIRE-1

Most Recent Events

22 Nov 2022 data According to a Blue Earth Diagnostics media release, data will be presented at the upcoming Radiological Society of North America (RSNA) 108th Scientific Assembly and Annual Meeting.
11 Jul 2022 Status changed from active, no longer recruiting to completed.
25 May 2021 Results published in Blue Earth Diagnostics Media Release

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com